Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Revenue (2020 - 2025)

Historic Revenue for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $30.3 million.

  • RxSight's Revenue fell 1408.51% to $30.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.1 million, marking a year-over-year increase of 1075.12%. This contributed to the annual value of $139.9 million for FY2024, which is 5708.54% up from last year.
  • Per RxSight's latest filing, its Revenue stood at $30.3 million for Q3 2025, which was down 1408.51% from $33.6 million recorded in Q2 2025.
  • RxSight's Revenue's 5-year high stood at $40.2 million during Q4 2024, with a 5-year trough of $3.5 million in Q1 2021.
  • Its 5-year average for Revenue is $21.2 million, with a median of $20.8 million in 2023.
  • Its Revenue has fluctuated over the past 5 years, first surged by 18945.75% in 2021, then plummeted by 1408.51% in 2025.
  • Quarter analysis of 5 years shows RxSight's Revenue stood at $8.4 million in 2021, then soared by 90.93% to $16.1 million in 2022, then skyrocketed by 77.65% to $28.6 million in 2023, then soared by 40.71% to $40.2 million in 2024, then dropped by 24.55% to $30.3 million in 2025.
  • Its Revenue was $30.3 million in Q3 2025, compared to $33.6 million in Q2 2025 and $37.9 million in Q1 2025.